The company has received approvals from Drug Controller General of India (DCGI), Central Drugs Standard Control Organisation (CDSCO) and Central Drug Laboratory (CDL) to market the tetravalent inactivated influenza vaccine Vaxiflu 4 for seasonal flu, Cadila Healthcare said in a filing to BSE.
An experimental Ebola vaccine has been found to be 100 per cent affective against the deadly virus in a major human trial in Guinea, giving doctors a safe and potent weapon against any future outbreak, WHO said today.
Vaccine manufacturing firm GreenSignal Bio Pharma has extended its initial public offer by three days to November 17 amid lukewarm response from investors.
The firm is engaged in manufacturing of BCG vaccine, given for protection against tuberculosis, mainly severe forms of childhood tuberculosis.
Sun Pharma will fund and support further development of the vaccine candidate and existing ICGEB knowhow and patents.
"As soon as the government approves the use of the Sanofi Pasteur dengue vaccine, it will take minimally 6-8 months to complete the remaining regulatory requirements and make the vaccine available to the Indian population," Baylet said.
In an interview with CNBC-TV18, Devi Shetty, Chairman of Narayana Hrudayalaya said that dengue is a global problem but India is not doing enough to prevent it.
The agreement includes early stage development to the final commercialisation of the vaccine.
The company is focusing on vaccinations for dengue and pneumonia solutions and sending them to Asian & African countries, said Adar Poonawalla,CEO & Executive Director, Serum Institute of India.
"The campaign, to be conducted from June 20 to 26, would be carried out at 700 booths," said Lalitha Kumari, Director of Public Health and Family Welfare.
The big demand from Budget 2016 is simple: spend more on healthcare. One suggestion to this end is that the government should take a leaf out of the Singapore government's book and create a universal healthcare insurance scheme.
The mosquito-transmitted Zika virus, which has the world on edge because of its newly-acquired pandemic status, may now have a cure â€“ a vaccine that's the first of its kind in the world.
If you think the restaurant has served stale food, return it. Should the restaurant refuse to accept their mistake and offer fresh food, go to another restaurant or if that is not an option, order something else. It doesn‘t make sense to save money here and pay for a doctor‘s bills later.
Hilleman Laboratories today said it is looking to tie up with vaccine specialty companies and government agencies to fund a Rs 300 project for developing some low cost vaccines in India.
Etna Biotech, a subsidiary of Zydus, will collaborate with US National Institutes of Health for research purpose.
The multi-layered deal involves UK-based GlaxoSmithKline (GSK) acquiring the Swiss major's vaccine business, while the latter would purchase GSK's cancer drugs portfolio.
The trial, which began on Sept. 2 and will monitor the volunteers for 48 weeks, is primarily aimed at assessing how safe the vaccine is. But the immune response offered hope that it would also be effective.
A new malaria vaccine, which is being developed in the US, has shown promising results in early stage clinical trials, scientists say. Researchers found that high doses of the vaccine protected 12 out of 15 patients from the disease.
Methicillin-resistant Staphylococcus aureus infects an estimated 53 million people globally and costs more than USD 20 billion a year to treat. In the United States alone, MRSA kills 20,000 Americans each year, exceeding annual deaths from AIDS.
Global drug major GlaxoSmithKline (GSK) and Hyderabad-based Biological E Ltd will set up a joint venture to develop a six-in-one vaccine for polio and other infectious diseases.
In Emanuel Adu's language, Twi, people call the skin cancer that is invading his cheek and nose "sasabro". It means a disease that eats away at you.
The world of pediatric vaccines is about to be shaken. And it's Hyderabad based Shantha Biotech that's going to do all the shaking
Big pharma is looking for immunity from a fall in revenues as blockbuster drugs go off patent. They are finding it in Indian vaccine makers